GAIL (India) Limited – Investor Presentation Summary

Key Operational Highlights

  • Natural Gas Transmission averaged 121.30 MMSCMD in H1 FY 2026-27
  • Petrochemical Sales: Volume not specified in presentation
  • Liquid Hydrocarbons Sales: Volume not specified in presentation
  • LPG Transmission: Volume not specified in presentation

Financial Highlights

Standalone Performance:
  • Turnover (Gross): ₹38,752 crore (Q2 FY27)
  • Profit Before Tax (PBT): ₹3,207 crore (Q2 FY27)
  • Profit After Tax (PAT): ₹2,373 crore (Q2 FY27), representing 11% YoY growth
  • Gross Margin (EBITDA): Amount not specified in presentation
Consolidated Performance (H1 FY 2026-27):
  • Turnover (Gross): ₹141,716 crore
  • Profit Before Tax (PBT): ₹11,237 crore
  • Profit After Tax (PAT): ₹8,521 crore
  • Historical comparison: FY23 ₹145,531 crore, FY24 ₹133,130 crore, FY25 ₹141,949 crore, FY26 ₹141,716 crore turnover

Capital Expenditure: H1 FY 2026-27

  • Total Capex: ₹7,600 crore (against annual planned capex of ~₹12,900 crore for FY2026-27)
  • Operational Capex (including ship chartering): ₹4,776 crore (63%)
  • Petrochemicals: ₹748 crore (10%)
  • Pipelines: ₹655 crore (9%)
  • Equity Contributions to JVs/Subsidiaries: ₹442 crore (6%)
  • CGD Projects: ₹389 crore (5%)
  • Net Zero/Renewables: ₹356 crore (4%)
  • Exploration & Production: ₹234 crore (3%)

Key Financial Ratios

  • Specific ratios not detailed in the presentation

Geographical Revenue Split

  • Not specified in presentation

Balance Sheet Snapshot

  • Not specified in presentation

Capex & Cash Flow Health

  • Capital Expenditure: ₹7,600 crore actual in H1 FY27 against annual plan of ~₹12,900 crore
  • Free Cash Flow: Not specified
  • Operating Cash Flow: Not specified
  • Net Debt Movement: Not specified

Strategic & R&D Initiatives

  • Investment focus areas: Operational capex, petrochemicals, pipelines, renewables, and exploration

Industry Trends & Business Environment

  • Not specified in presentation

Management Commentary & Growth Outlook

  • Presentation scheduled for earnings conference call on 30.10.2026 at 04:30 PM (IST)
  • Specific guidance and outlook not detailed in the presentation document

Event Context

  • This is an investor presentation for Q2 FY 2026-27 results
  • Disclosure made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Presentation date: 30.10.2026